Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXPF | AMGN | BMY | GILD | VRTX |
| Company | Cybin Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 3.0500 | 269.96 | 49.40 | 76.78 | 355.11 |
| High | 3.2000 | 272.59 | 50.18 | 77.66 | 356.71 |
| Low | 2.8736 | 267.62 | 48.93 | 76.20 | 350.23 |
| Last | 3.0200 | 272.45 | 50.10 | 77.65 | 351.16 |
| Change | -0.0400 | +2.81 | +0.72 | +1.05 | -3.65 |
| % Change | -1.31% | +1.04% | +1.46% | +1.37% | -1.03% |
| Volume | 864,300 | 2,303,900 | 12,806,400 | 5,400,400 | 1,135,100 |
| 20-Day Average Volume | 1,094,590 | 2,176,395 | 14,261,635 | 6,600,765 | 1,556,850 |
| Previous Close | 3.0600 | 269.64 | 49.38 | 76.60 | 354.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.8482 | 267.96 | 50.40 | 76.37 | 361.16 |
| 20-Day Raw Stochastic | 71.64% | 82.68% | 34.88% | 42.56% | 20.34% |
| 20-Day Relative Strength | 62.45% | 54.51% | 40.22% | 53.37% | 45.64% |
| Weighted Alpha | +130.72 | +2.90 | -39.10 | -10.50 | +9.60 |
| Today's Opinion | N/A | 72% Buy | 100% Sell | 40% Sell | 40% Buy |
| Previous Opinion | N/A | 56% Buy | 100% Sell | 88% Sell | 40% Buy |
| Last Month's Opinion | N/A | 56% Buy | 100% Sell | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.46% since 07/28/21 | +2.63% since 11/24/23 | +0.68% since 11/24/23 | +3.01% since 11/24/23 | -0.53% since 11/24/23 |
| Low | 2.7300 on 07/29/21 | 261.66 on 11/27/23 | 48.25 on 11/30/23 | 74.19 on 11/28/23 | 346.29 on 11/28/23 |
| High | 3.3800 on 08/02/21 | 272.59 on 12/01/23 | 50.18 on 12/01/23 | 77.66 on 12/01/23 | 356.71 on 12/01/23 |
| 1-Month | |||||
| %Chg | +42.45% since 07/02/21 | +4.45% since 11/01/23 | -2.30% since 11/01/23 | -3.17% since 11/01/23 | -4.92% since 11/01/23 |
| Low | 2.1105 on 07/08/21 | 260.52 on 11/21/23 | 48.25 on 11/30/23 | 73.99 on 11/16/23 | 341.90 on 11/16/23 |
| High | 3.3800 on 08/02/21 | 274.95 on 11/06/23 | 53.55 on 11/06/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| 3-Month | |||||
| %Chg | +79.76% since 05/04/21 | +6.13% since 09/01/23 | -19.22% since 09/01/23 | +1.30% since 09/01/23 | +0.02% since 09/01/23 |
| Low | 1.3429 on 06/01/21 | 248.38 on 09/06/23 | 48.25 on 11/30/23 | 72.87 on 10/03/23 | 340.83 on 09/06/23 |
| High | 3.3800 on 08/02/21 | 288.46 on 10/13/23 | 62.00 on 09/05/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| 6-Month | |||||
| %Chg | +76.61% since 02/04/21 | +27.15% since 06/01/23 | -22.54% since 06/01/23 | +1.89% since 06/01/23 | +8.51% since 06/01/23 |
| Low | 0.9500 on 03/30/21 | 212.02 on 06/02/23 | 48.25 on 11/30/23 | 72.87 on 10/03/23 | 322.24 on 06/02/23 |
| High | 3.3800 on 08/02/21 | 288.46 on 10/13/23 | 66.46 on 06/05/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 453,224 | 144,305,408 | 100,476,360 | 95,446,808 | 91,428,512 |
| Shares Outstanding, K | 148,598 | 535,178 | 2,034,758 | 1,246,042 | 257,683 |
| Annual Sales | 650,000 | 26,323,000,000 | 46,159,000,000 | 27,281,000,000 | 8,930,700,000 |
| Annual Net Income | -24,420,000 | 6,552,000,000 | 6,327,000,000 | 4,592,000,000 | 3,322,000,000 |
| Last Quarter Sales | N/A | 6,903,000,000 | 10,966,000,000 | 7,051,000,000 | 2,483,500,000 |
| Last Quarter Net Income | N/A | 1,730,000,000 | 1,928,000,000 | 2,180,000,000 | 1,035,300,000 |
| 60-Month Beta | N/A | 0.58 | 0.38 | 0.32 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.96 on 10/31/23 | 2.00 on 10/26/23 | 2.29 on 11/07/23 | 4.08 on 11/06/23 |
| Latest Earnings Date | N/A | 10/31/23 | 10/26/23 | 11/07/23 | 11/06/23 |
| Most Recent Dividend | N/A | 2.130 on 11/16/23 | 0.570 on 10/05/23 | 0.750 on 09/14/23 | N/A |
| Next Ex-Dividends Date | N/A | 11/16/23 | 10/05/23 | 12/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.79 | 6.39 | 11.28 | 26.59 |
